# ONCOVISTA INNOVATIVE THERAPIES, INC

ONCOVISTA INNOVATIVE THERAPIES, INC is a company headquartered in San Antonio, TX, United States.

## Company overview

- **Legal name:** ONCOVISTA INNOVATIVE THERAPIES, INC
- **Former names in filing history:** AVIATION UPGRADE TECHNOLOGIES INC (1999-12-02 to 2008-01-08)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Antonio, TX, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001094847

## About

ONCOVISTA INNOVATIVE THERAPIES, INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001094847, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2015-04-15, it reported annual revenue of USD 0; net income of USD -2,544,393; total assets of USD 12,514 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$2.5M (USD -2,544,393)
- **Total assets:** $12,514 (USD 12,514)
- **Cash and equivalents:** $12,514 (USD 12,514)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$1.4M (USD -1,449,613)
- **Total assets:** $96,320 (USD 96,320)
- **Cash and equivalents:** $44,898 (USD 44,898)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$1.6M (USD -1,628,768)
- **Total assets:** $575,266 (USD 575,266)
- **Cash and equivalents:** $511,687 (USD 511,687)
- **Operating cash flow:** -$1.6M (USD -1,553,799)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$2.0M (USD -2,025,192)
- **Total assets:** $2.2M (USD 2,188,619)
- **Cash and equivalents:** $2.1M (USD 2,125,229)
- **Operating cash flow:** -$1.6M (USD -1,608,920)

## Recent SEC filings

- Form SC 13G — filed 2016-04-27 — NONE
- Form 10-Q — filed 2015-11-12 — period 2015-09-30 — FORM 10-Q
- Form SC 13G — filed 2015-09-08
- Form 10-Q — filed 2015-08-14 — period 2015-06-30 — FORM 10-Q
- Form 10-Q — filed 2015-05-15 — period 2015-03-31 — FORM 10-Q
- Form 10-K — filed 2015-04-15 — period 2014-12-31 — 10-K
- Form 10-Q — filed 2014-11-13 — period 2014-09-30 — 10-Q
- Form 10-Q — filed 2014-08-12 — period 2014-06-30 — 10-Q
- Form 10-Q — filed 2014-05-09 — period 2014-03-31 — 10-Q
- Form 10-K — filed 2014-04-14 — period 2013-12-31 — 10-K
- Form 10-Q — filed 2013-11-14 — period 2013-09-30 — QUARTERLY REPORT
- Form 10-Q — filed 2013-08-14 — period 2013-06-30 — 10-Q

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/oncovista-innovative-therapies-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology